CYP
Click for more information
8.62% 26.5¢ cynata therapeutics limited

Ann: Strategic Review of Cynata Clinical Development Portfolio, page-4

  1. Hiepn2_2005
    1,480 Posts.
    lightbulb Created with Sketch. 138
    clock Created with Sketch.
    24/07/23
    14:08
    Post #: 68947313
    Good to see recruitment for the phase 3 osteoarthritis is going well.
    CYP Price at posting: 13.5¢ Sentiment: Buy Disclosure: Held
    Likes Created with Sketch. 6  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

A1M Swagman shoot proves plentiful for AIC, with Cu beyond 3% close to Eloise
right-arrow Created with Sketch.
EMD Emyria and UWA secure $499,411 grant to advance MDMA analogue drug program
right-arrow Created with Sketch.
EX1 Tryptamine Therapeutics completes maiden dosing of IV psilocin – a global first
right-arrow Created with Sketch.
NEWS Wealth Within weighs in on shock 4% inflation read – and stocks that could survive the gloom
right-arrow Created with Sketch.
LRV Larvotto identifies new exploration target at NSW's Hillgrove, boosting shares by nearly 20%
right-arrow Created with Sketch.
ITM iTech lifts MRE at Eyre Peninsula Graphite Project by 300%
right-arrow Created with Sketch.
watchlist Created with Sketch. Add CYP (ASX) to my watchlist
(20min delay)
Last
26.5¢ 		Change
-0.025(8.62%) 		Mkt cap ! $47.60M
Open High Low Value Volume
28.5¢ 28.5¢ 26.5¢ $30.17K 112.9K

Buyers (Bids)

No. Vol. Price($)
2 28895 26.5¢
 

Sellers (Offers)

Price($) Vol. No.
28.5¢ 500 1
View Market Depth
Last trade - 16.10pm 04/07/2024 (20 minute delay) ?
CYP (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.